IREB2 and chronic obstructive pulmonary disease: Our current study suggests that genetic modifier effects of IREB2 and CHRNA3 may be more prominent in males--potentially contributing to some of the sex-specific features of COPD susceptibility and severity among PI ZZ subjects, although a larger sample size is needed to verify a gene-by-sex interaction.